Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine
- PMID: 23298209
- DOI: 10.1146/annurev-immunol-032712-095919
Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine
Abstract
Mesenchymal stem cells (MSCs) are self-renewing precursor cells that can differentiate into bone, fat, cartilage, and stromal cells of the bone marrow. Recent studies suggest that MSCs themselves are critical for forming a niche that maintains hematopoietic stem cells (HSCs). The ease by which human MSC-like and stromal progenitor cells can be isolated from the bone marrow and other tissues has led to the rapid development of clinical investigations exploring their anti-inflammatory properties, tissue preservation capabilities, and regenerative potential. However, the identity of genuine MSCs and their specific contributions to these various beneficial effects have remained enigmatic. In this article, we examine the definition of MSCs and discuss the importance of rigorously characterizing their stem cell activity. We review their role and that of other putative niche constituents in the regulation of bone marrow HSCs. Additionally, how MSCs and their stromal progeny alter immune function is discussed, as well as potential therapeutic implications.
Similar articles
-
Dual-Double Stem Cell Ovarian Therapy: A Comprehensive Approach in Regenerative Medicine.Int J Mol Sci. 2024 Dec 25;26(1):69. doi: 10.3390/ijms26010069. Int J Mol Sci. 2024. PMID: 39795929 Free PMC article. Review.
-
Implications of mesenchymal stem cells in regenerative medicine.Artif Cells Nanomed Biotechnol. 2016 May;44(3):749-57. doi: 10.3109/21691401.2015.1129620. Epub 2016 Jan 13. Artif Cells Nanomed Biotechnol. 2016. PMID: 26757594 Review.
-
Intramarrow injection of beta-catenin-activated, but not naive mesenchymal stromal cells stimulates self-renewal of hematopoietic stem cells in bone marrow.Exp Mol Med. 2010 Feb 28;42(2):122-31. doi: 10.3858/emm.2010.42.2.014. Exp Mol Med. 2010. PMID: 20054234 Free PMC article.
-
Clinical Trials With Mesenchymal Stem Cells: An Update.Cell Transplant. 2016;25(5):829-48. doi: 10.3727/096368915X689622. Epub 2015 Sep 29. Cell Transplant. 2016. PMID: 26423725 Review.
-
Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.J Korean Med Sci. 2006 Dec;21(6):1000-4. doi: 10.3346/jkms.2006.21.6.1000. J Korean Med Sci. 2006. PMID: 17179676 Free PMC article.
Cited by
-
Lenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC.Int J Hematol. 2024 Sep;120(3):278-289. doi: 10.1007/s12185-024-03815-y. Epub 2024 Jul 12. Int J Hematol. 2024. PMID: 38995485 Free PMC article.
-
Tapping Stem Cells to Target AMD: Challenges and Prospects.J Clin Med. 2015 Jan 29;4(2):282-303. doi: 10.3390/jcm4020282. J Clin Med. 2015. PMID: 26239128 Free PMC article. Review.
-
Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection.Mol Ther Methods Clin Dev. 2021 Jun 11;21:754-764. doi: 10.1016/j.omtm.2021.05.004. Epub 2021 May 14. Mol Ther Methods Clin Dev. 2021. PMID: 34007862 Free PMC article.
-
Inflammatory bone marrow microenvironment.Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):294-302. doi: 10.1182/hematology.2019000045. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808897 Free PMC article. Review.
-
Immunomodulatory functions of human mesenchymal stromal cells are enhanced when cultured on HEP/COL multilayers supplemented with interferon-gamma.Mater Today Bio. 2021 Dec 23;13:100194. doi: 10.1016/j.mtbio.2021.100194. eCollection 2022 Jan. Mater Today Bio. 2021. PMID: 35005599 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources